Multimodal Analgesia Effect on Post Surgical Patient
Obesity, Morbid, Surgery, Bariatric Surgery Candidate
About this trial
This is an interventional treatment trial for Obesity, Morbid focused on measuring Bariatric Surgery,, Pain Control, Gabapentinin
Eligibility Criteria
Inclusion Criteria:
- Women who undergo index weight loss procedures at UC Davis Medical Center
- Women with a BMI =>30
- Age from 35-65
- American Society of Anesthesiology (ASA) score of 3 or less
- No previous history of prior abdominal/foregut surgery
Exclusion Criteria:
- Not having an index weight los surgery for obesity
- Do not meet the NIH Standards for weight loss surgery
- Additional planned or unplanned procedures during the index surgical procedure such as Cholecystectomy or extensive lysis of adhesions (>30 minutes)
- BMI < 30
- Men
- Women considering or currently planning on gender altering/modification
- ASA score of 4 or higher
- Patients less than 35 years of age or older than 65 years of age at the time of surgical consent
- A history of open abdominal surgery including umbilical, ventral, or splengalic hernia repair with or without mesh implantation, transplant or vascular surgery or any foregut procedures including hiatal hernia repair or anti-reflux surgery
- Arthritis, Fibromyalgia, chronic pain syndrome
- Other conditions requiring daily use of oral pain medications
- Prisoners
- Allergy to Gabapentin
Sites / Locations
- UC Davis HealthRecruiting
Arms of the Study
Arm 1
Arm 2
Active Comparator
Experimental
Standard of Care
Multi-Modal
The group will receive the standard of care pain control protocol after index Bariatric Surgery which includes the use of a PCA (patient controlled analgesia) with Dilaudid or Morphine Sulphate, transitioning to oral narcotic based pain control medications.
Patients will receive Gabapentin pre-operatively on-call 120 minutes prior to surgery starting. Patients at the conclusion of surgery will have additional doses of Ofirmev (IV Tylenol) and Gabapentin via IV based on patients pre-operative weight. Post surgery the patient will be transitioned to oral pain medications (Tylenol and Gabapentin) with rescue medications available for breakthrough pain control.